These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2147956)

  • 1. Synthesis and dopamine receptor affinity of (R)-(-)-2-fluoro-N-n-propylnorapomorphine: a highly potent and selective dopamine D2 agonist.
    Neumeyer JL; Gao YG; Kula NS; Baldessarini RJ
    J Med Chem; 1990 Dec; 33(12):3122-4. PubMed ID: 2147956
    [No Abstract]   [Full Text] [Related]  

  • 2. R(-)2-fluoro-N-n-propylnorapomorphine: a very potent and D2-selective dopamine agonist.
    Baldessarini RJ; Kula NS; Gao Y; Campbell A; Neumeyer JL
    Neuropharmacology; 1991 Jan; 30(1):97-9. PubMed ID: 1675452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structural requirements of N-substituted norapomorphines for affinity and activity at dopamine D-1, D-2, and agonist receptor sites in rat brain.
    Gao YG; Ram VJ; Campbell A; Kula NS; Baldessarini RJ; Neumeyer JL
    J Med Chem; 1990 Jan; 33(1):39-44. PubMed ID: 2136919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanadate inhibits agonist binding to D2 dopamine receptor.
    Elazar Z; Fuchs S
    J Mol Neurosci; 1991; 3(1):1-6. PubMed ID: 1679343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and dopamine receptor affinities of enantiomers of 2-substituted apomorphines and their N-n-propyl analogues.
    Gao YG; Baldessarini RJ; Kula NS; Neumeyer JL
    J Med Chem; 1990 Jun; 33(6):1800-5. PubMed ID: 1971309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation by cyclic AMP-dependent protein kinase modulates agonist binding to the D2 dopamine receptor.
    Elazar Z; Fuchs S
    J Neurochem; 1991 Jan; 56(1):75-80. PubMed ID: 1846178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous distribution of dopamine D2 receptors within the rat striatum as revealed by autoradiography of [3H]N-n-propylnorapomorphine binding sites.
    Dubois A; Scatton B
    Neurosci Lett; 1985 Jun; 57(1):7-12. PubMed ID: 3162114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
    Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ
    Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.
    Cumming P; Wong DF; Gillings N; Hilton J; Scheffel U; Gjedde A
    J Cereb Blood Flow Metab; 2002 May; 22(5):596-604. PubMed ID: 11973432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin peptides in vitro modulate the characteristics of the striatal 3H-N-propylnorapomorphine sites.
    Agnati LF; Celani MF; Fuxe K
    Acta Physiol Scand; 1983 May; 118(1):79-81. PubMed ID: 6312748
    [No Abstract]   [Full Text] [Related]  

  • 13. Correspondency between different affinity states and target size of the bovine striatal D2 dopamine receptor.
    Kuno T; Tanaka C
    Biochem Biophys Res Commun; 1983 Nov; 117(1):65-70. PubMed ID: 6197972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptic concentration of dopamine in the mouse striatum in relationship to the kinetic properties of the dopamine receptors and uptake mechanism.
    Ross SB
    J Neurochem; 1991 Jan; 56(1):22-9. PubMed ID: 1824780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Haloaporphines as potent dopamine agonists.
    Ramsby S; Neumeyer JL; Grigoriadis D; Seeman P
    J Med Chem; 1989 Jun; 32(6):1198-201. PubMed ID: 2524592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor-modulated [35S]GTPgammaS binding in striatum of 6-hydroxydopamine-lesioned rats.
    Geurts M; Hermans E; Cumps J; Maloteaux JM
    Brain Res; 1999 Sep; 841(1-2):135-42. PubMed ID: 10546996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupation of dopamine receptors by N-n-propylnorapomorphine or spiperone and acetylcholine levels in the rat striatum.
    Korf J; Sebens JB; Flentge F; van der Werf JF
    J Neurochem; 1985 Jan; 44(1):314-8. PubMed ID: 3964835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin decreases the affinity of dopamine D2 agonist binding by a G protein-independent mechanism.
    von Euler G; van der Ploeg I; Fredholm BB; Fuxe K
    J Neurochem; 1991 Jan; 56(1):178-83. PubMed ID: 1824779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlated asymmetries in striatal D1 and D2 binding: relationship to apomorphine-induced rotation.
    Glick SD; Lyon RA; Hinds PA; Sowek C; Titeler M
    Brain Res; 1988 Jul; 455(1):43-8. PubMed ID: 2970881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.